SARS-CoV-2 May Become Resistant, Mutate After Sotrovimab Treatment

Patients who receive one of the few antibody treatments that works against the Omicron variant must be carefully monitored because, after the drug is infused, the virus may mutate and become resistant to it, researchers warn.
Reuters Health Information

source https://www.medscape.com/viewarticle/970180?src=rss

Comments

Popular posts from this blog

Student Nurses Who Refuse Vaccination Struggle to Complete Degrees

The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors